Aspen Neuroscience

Aspen Neuroscience is a development stage, private biotechnology company focused on personalized (autologous) cell therapies.

Constellation Orion

Biotech

Oryon shines out of stealth with $21M to fight Parkinson's

Oryon Cell Therapies is launching with a $21 million series A round and announcing that physician entrepreneur Ron Cohen, M.D., will be its CEO.

Will Maddox Mar 23, 2026 5:00am

Small sprouting plant starting to grow

Aspen's Parkinson's cell therapy data plant seeds for ph. 3

Mar 18, 2026 9:00am

Grove of aspen trees with golden leaves

Aspen adds $115M series C to grow cell therapy ambitions

Nov 20, 2025 7:02am

Parachute

FDA shores up executive team with 2 hires—Chutes & Ladders

Jul 1, 2022 9:30am

Aspen tree root trees forest leaves trunks

Aspen takes root with $147M funding for Parkinson's therapy

May 9, 2022 11:28am